Who We Are
Nice to Meet You
Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, intelligent, and mobile.
Kestra innovations empower providers and patients to collaborate towards better care and improved outcomes.
Kestra’s Mission is to provide innovative, intuitive medical technologies to protect and support at-risk patients.
Our Team of professionals with deep expertise in Class III therapeutic medical devices works together focused on our Core principles of innovation, collaboration, and execution.
Kestra's initial product, the ASSURE® system, includes the ASSURE WCD, ASSURE patient app, and Kestra CareStation™ remote patient data platform, designed to work in concert to offer confidence, comfort, and connection to patients—and clarity for healthcare providers.ASSURE Cardiac Recovery System
A wearable device for patients at risk of sudden cardiac arrest that can provide automatic detection and defibrillation for ventricular arrhythmias.ASSURE Cardiac Recovery System
The Kestra CareStation platform is a cloud-based remote patient data platform, providing relevant data for doctors, allowing them to conveniently track patient progress and receive notifications.Kestra CareStation
ASSURE Patient App
The ASSURE patient app is a convenient mobile application which automatically transmits data to care teams via the Kestra CareStation remote patient data platform at certain time intervals or when a patient chooses to transmit. The app also allows patients to watch educational videos, track their physical activity and usage time, access troubleshooting information, and empowers patient self-management of his or her recovery.ASSURE Patient App
Empathy Powered Design
Kestra deploys a design approach we call Empathy Powered Design™ that focuses intensively on the patient experience—and the experience of those who care for them, both healthcare providers and patients’ loved ones and families.
As Kestra grows, we aim to create best-in-class products and platforms through active research and product development, always putting safety, efficacy, ease of use, and patient and caregiver empowerment at the forefront.
Kestra was founded in 2014 by leaders from the automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD) industries, who were inspired to develop modern, wearable, advanced technology diagnostic and therapy products.
President and Chief Executive Officer
General Counsel and Chief Administrative Officer
Chief Financial Officer
Vice President, Research & Development
Senior Vice President, Marketing
Senior Vice President, Commercial Operations
Vice President, Quality and Regulatory Affairs
Vice President, Operations and Supply Chain
Vice President, IT & Customer Experience
Vice President, Finance
Vice President, Clinical Marketing
Board of Directors
Nicholas Downing, MD
Mary Kay Ladone
Join Our Team
At Kestra we offer opportunities to work on unique projects, across multiple disciplines, in a collaborative, creative, and fast-paced environment. We foster innovation, reward performance, and have fun.
Compliance and Ethics
Kestra maintains a continuing commitment to conducting our business honestly, ethically, and in accordance with applicable laws, with respect to our team members, customers, marketplace, and global community.
We are guided by our Code of Conduct and Business Code of Conduct, which are continually reviewed and enhanced as appropriate or as required by applicable laws and regulations.
Kestra is committed to being a responsible business, beginning with the four commitments in the Kestra Code of Conduct which advance the principles of Environmental, Social, and Governance (ESG).
Kestra's commitments to local and global communities, patients and providers, the marketplace, and our own Team support a respectful, inclusive, engaged culture where integrity, quality, trust, and community are paramount.
Explore snapshots of our ESG journey at Kestra.
Women in Leadership
Kestra prioritizes supporting and developing women in leadership, meeting the unique needs of female cardiac patients, and empowering women practitioners in all areas of Cardiology and Electrophysiology.
That’s just one of our commitments to Diversity, Equity, and Inclusion (DEI), all of which contribute to building and growing our broadly inclusive company culture.
Team Engagement in ESG
Team members across the country are highly engaged in five Kestra ESG committees, each of which offers opportunities to lead, participate and make a difference. They include Diversity, Equity and Inclusion (DEI), Philanthropy, Professional Development, Networking, and Mentoring committees.
Measuring and reporting on Team engagement in ESG helps us keep ourselves accountable for strengthening the culture of Kestra by putting our values into action.
Our Team supports an array of local and national community impact organizations. This includes nonprofits like Mary’s Place, which provides safe, inclusive shelter for women, children and families on their journey out of homelessness. Kestra has supported their mission of “No child sleeps outside” since the company’s founding.
Additional philanthropy efforts have supported organizations including Bloodworks Northwest and the American Heart Association.
Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System
Insurer Positive Coverage Decisions Announced
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices
ASSURE Wearable Cardioverter Defibrillator (WCD) System Demonstrates Low False Alarm Rates, High Patient Compliance in Clinical Study
Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system is effective at reducing false shock alarms and improving patient comfort, according to results of the ASSURE WCD Clinical Evaluation - Detection and Safety Study
Kestra Medical Technologies Receives FDA Premarket Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)
Kestra™ Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE® (WCD) system.
Kestra is a closely held private company and a portfolio company of Bain Capital, one of the world’s leading alternative investment firms with deep global experience in healthcare.
Contact Investor Relations